TY - JOUR
T1 - Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma
AU - Konstas, Anastasios G.P.
AU - Quaranta, Luciano
AU - Mikropoulos, Dimitrios G.
AU - Nasr, Mayssa B.
AU - Russo, Andrea
AU - Jaffee, Harris A.
AU - Stewart, Jeanette A.
AU - Stewart, William C.
PY - 2012/2/1
Y1 - 2012/2/1
N2 - Purpose: To evaluate the effect of 24-h peak intraocular pressure (IOP) on the progression of primary open-angle glaucoma (POAG) and the 24h time points that best predict peak pressure. Methods: A retrospective analysis of clinical data evaluating long-term glaucomatous progression in patients with POAG who were previously in a 24-h study of the authors (IOP readings at 2/6/10 A.M. and 2/6/10 PM); had ≥3 treated 10 A.M. (±1h) IOP measurements over 5-years after an untreated 24-h baseline; and had a treated 24-h curve with a 10 A.M. IOP±2mmHg within the 10 A.M. mean IOP over 5-years. Results: We included 98 nonprogressed and 53 progressed patients with POAG (n=151). The mean 24-h peak IOP (mmHg) was 19.9±2.7 for progressed and 18.3±2.0 for nonprogressed patients (P<0.001). Progressed patients also showed a higher mean 24-h IOP. Generally, patients with a mean or peak daytime (readings at 10 A.M., 2 and 6 P.M.) or 24-h peak IOP of ≤18 remained nonprogressed in 75%-78% of cases. Further, measuring IOP at night found a higher peak in only 20% of cases, which was ≤2 of the daytime peak in 98% of cases. A multivariate regression analysis showed only 24-h peak IOP as an independent risk factor for progression (P=0.002). Conclusions: This study suggests that daytime peak IOP may be clinically important in predicting long-term glaucomatous progression. Further, daytime peak IOP may assist, as much as daytime mean IOP and, in most cases, 24-h peak IOP, in helping to guide long-term treatment in POAG.
AB - Purpose: To evaluate the effect of 24-h peak intraocular pressure (IOP) on the progression of primary open-angle glaucoma (POAG) and the 24h time points that best predict peak pressure. Methods: A retrospective analysis of clinical data evaluating long-term glaucomatous progression in patients with POAG who were previously in a 24-h study of the authors (IOP readings at 2/6/10 A.M. and 2/6/10 PM); had ≥3 treated 10 A.M. (±1h) IOP measurements over 5-years after an untreated 24-h baseline; and had a treated 24-h curve with a 10 A.M. IOP±2mmHg within the 10 A.M. mean IOP over 5-years. Results: We included 98 nonprogressed and 53 progressed patients with POAG (n=151). The mean 24-h peak IOP (mmHg) was 19.9±2.7 for progressed and 18.3±2.0 for nonprogressed patients (P<0.001). Progressed patients also showed a higher mean 24-h IOP. Generally, patients with a mean or peak daytime (readings at 10 A.M., 2 and 6 P.M.) or 24-h peak IOP of ≤18 remained nonprogressed in 75%-78% of cases. Further, measuring IOP at night found a higher peak in only 20% of cases, which was ≤2 of the daytime peak in 98% of cases. A multivariate regression analysis showed only 24-h peak IOP as an independent risk factor for progression (P=0.002). Conclusions: This study suggests that daytime peak IOP may be clinically important in predicting long-term glaucomatous progression. Further, daytime peak IOP may assist, as much as daytime mean IOP and, in most cases, 24-h peak IOP, in helping to guide long-term treatment in POAG.
UR - http://www.scopus.com/inward/record.url?scp=84856888767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856888767&partnerID=8YFLogxK
U2 - 10.1089/jop.2011.0081
DO - 10.1089/jop.2011.0081
M3 - Article
C2 - 22004074
AN - SCOPUS:84856888767
SN - 1080-7683
VL - 28
SP - 26
EP - 32
JO - Journal of Ocular Pharmacology
JF - Journal of Ocular Pharmacology
IS - 1
ER -